Research-Grade Pharmaceutical Overview
Suminat 50 mg by Sun Pharmaceuticals Industries is a pharmaceutical-grade sumatriptan formulation designed for in-vitro laboratory research investigating triptan receptor mechanisms and vascular pharmacology. This preparation provides researchers studying neurological pathways with a standardised compound for examining 5-HT1B and 5-HT1D receptor interactions in controlled laboratory environments. At Stroid UK Shop, we supply authentic pharmaceutical preparations to support rigorous research protocols examining migraine pathophysiology and serotonin receptor biology.
Laboratory Research Applications
Research teams examining sumatriptan utilise this compound to investigate selective serotonin receptor agonism and its effects on cranial vasculature in experimental models. Studies focus on 5-HT1B/1D receptor binding characteristics, receptor selectivity profiles, and downstream signalling cascades involved in vascular smooth muscle contraction. The compound serves as a reference standard for comparative pharmacological studies examining triptan class mechanisms and receptor pharmacology. Research applications extend to investigating bioavailability parameters, metabolic pathways, and pharmacokinetic profiles in laboratory settings. Scientists studying sumatriptan research compounds often examine dose-response relationships and receptor binding affinities using standardised pharmaceutical preparations. Additional research directions include examining drug-drug interactions, metabolite formation, and tissue distribution patterns in experimental models. This preparation enables researchers to investigate antimigraine mechanisms and compare efficacy profiles with other selective receptor modulators and peptide therapeutics in comprehensive pharmacological studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Sumatriptan 50 mg |
| Manufacturer | Sun Pharmaceuticals Industries |
| Formulation | Pharmaceutical tablet |
| CAS Number | 103628-46-2 (sumatriptan) |
| Molecular Formula | C₁₄H₂₁N₃O₂S |
| Molecular Weight | 295.40 g/mol |
| Storage Temperature | Room temperature, dry environment |
| Research Applications | 5-HT receptor studies, vascular pharmacology |
Research Compliance Statement
Suminat 50 mg is supplied exclusively for in-vitro research purposes by qualified laboratories studying serotonin receptor pharmacology and migraine mechanisms. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must possess appropriate institutional approval and safety protocols when handling this compound. All studies should comply with relevant research guidelines and institutional review board requirements for pharmaceutical research.
